Loading...

Mercator Medical

WSE:MRC
Snowflake Description

Moderate growth potential with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MRC
WSE
PLN73M
Market Cap
  1. Home
  2. PL
  3. Healthcare
Company description

Mercator Medical S.A., together with its subsidiaries, produces medical gloves and distributes medical disposables primarily in Poland, other European countries, and Russia. The last earnings update was 61 days ago. More info.


Add to Portfolio Compare Print
  • Mercator Medical has significant price volatility in the past 3 months.
MRC Share Price and Events
7 Day Returns
8.2%
WSE:MRC
0.5%
PL Medical Equipment
-0%
PL Market
1 Year Returns
-61.9%
WSE:MRC
-43.3%
PL Medical Equipment
3.1%
PL Market
MRC Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Mercator Medical (MRC) 8.2% -0.9% 0.7% -61.9% -53.4% -39.5%
PL Medical Equipment 0.5% -0.1% 4.1% -43.3% -71.2% -79.5%
PL Market -0% 1.4% -2.8% 3.1% 15.1% -4.4%
1 Year Return vs Industry and Market
  • MRC underperformed the Medical Equipment industry which returned -43.3% over the past year.
  • MRC underperformed the Market in Poland which returned 3.1% over the past year.
Price Volatility
MRC
Industry
5yr Volatility vs Market

Value

 Is Mercator Medical undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Mercator Medical. This is due to cash flow or dividend data being unavailable. The share price is PLN6.85.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Mercator Medical's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Mercator Medical's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
WSE:MRC PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in PLN PLN-0.05
WSE:MRC Share Price ** WSE (2019-07-17) in PLN PLN6.85
Europe Medical Equipment Industry PE Ratio Median Figure of 59 Publicly-Listed Medical Equipment Companies 31.92x
Poland Market PE Ratio Median Figure of 455 Publicly-Listed Companies 10.8x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Mercator Medical.

WSE:MRC PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= WSE:MRC Share Price ÷ EPS (both in PLN)

= 6.85 ÷ -0.05

-134.08x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Mercator Medical is loss making, we can't compare its value to the Europe Medical Equipment industry average.
  • Mercator Medical is loss making, we can't compare the value of its earnings to the Poland market.
Price based on expected Growth
Does Mercator Medical's expected growth come at a high price?
Raw Data
WSE:MRC PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -134.08x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
29.7%per year
Europe Medical Equipment Industry PEG Ratio Median Figure of 41 Publicly-Listed Medical Equipment Companies 2.51x
Poland Market PEG Ratio Median Figure of 105 Publicly-Listed Companies 1.19x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Mercator Medical, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Mercator Medical's assets?
Raw Data
WSE:MRC PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in PLN PLN12.54
WSE:MRC Share Price * WSE (2019-07-17) in PLN PLN6.85
Poland Medical Equipment Industry PB Ratio Median Figure of 11 Publicly-Listed Medical Equipment Companies 0.94x
Poland Market PB Ratio Median Figure of 684 Publicly-Listed Companies 0.97x
WSE:MRC PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= WSE:MRC Share Price ÷ Book Value per Share (both in PLN)

= 6.85 ÷ 12.54

0.55x

* Primary Listing of Mercator Medical.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Mercator Medical is good value based on assets compared to the PL Medical Equipment industry average.
X
Value checks
We assess Mercator Medical's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Mercator Medical has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Mercator Medical expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Mercator Medical, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
29.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Mercator Medical expected to grow at an attractive rate?
  • Mercator Medical's earnings growth is expected to exceed the low risk savings rate of 2.9%.
Growth vs Market Checks
  • Mercator Medical's earnings growth is expected to exceed the Poland market average.
  • Unable to compare Mercator Medical's revenue growth to the Poland market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
WSE:MRC Future Growth Rates Data Sources
Data Point Source Value (per year)
WSE:MRC Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 29.7%
Europe Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 18.1%
Europe Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.1%
Poland Market Earnings Growth Rate Market Cap Weighted Average 10.2%
Poland Market Revenue Growth Rate Market Cap Weighted Average 5.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
WSE:MRC Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in PLN Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
WSE:MRC Future Estimates Data
Date (Data in PLN Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
WSE:MRC Past Financials Data
Date (Data in PLN Millions) Revenue Cash Flow Net Income *
2019-03-31 452 24 -1
2018-12-31 420 -8 7
2018-09-30 364 7 9
2018-06-30 330 9 10
2018-03-31 316 22 10
2017-12-31 301 24 5
2017-09-30 292 9 5
2017-06-30 284 9 8
2017-03-31 278 19 11
2016-12-31 264 17 14
2016-09-30 259 19 14
2016-06-30 254 13 11

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Mercator Medical's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if Mercator Medical is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
WSE:MRC Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Mercator Medical Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WSE:MRC Future Estimates Data
Date (Data in PLN Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
WSE:MRC Past Financials Data
Date (Data in PLN Millions) EPS *
2019-03-31 -0.05
2018-12-31 0.71
2018-09-30 0.87
2018-06-30 0.91
2018-03-31 0.93
2017-12-31 0.47
2017-09-30 0.50
2017-06-30 0.79
2017-03-31 1.16
2016-12-31 1.50
2016-09-30 1.59
2016-06-30 1.31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Mercator Medical will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Mercator Medical's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Mercator Medical has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Mercator Medical performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Mercator Medical's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Mercator Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Mercator Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Mercator Medical's 1-year growth to the Europe Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Mercator Medical's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Mercator Medical Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WSE:MRC Past Revenue, Cash Flow and Net Income Data
Date (Data in PLN Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 452.49 -0.54 71.38
2018-12-31 420.41 7.47 64.75
2018-09-30 364.47 9.18 57.85
2018-06-30 329.64 9.61 51.94
2018-03-31 316.29 9.83 46.43
2017-12-31 300.76 4.93 43.22
2017-09-30 292.20 5.31 41.12
2017-06-30 283.64 8.08 40.03
2017-03-31 277.75 11.34 39.68
2016-12-31 263.59 13.90 37.72
2016-09-30 259.37 13.74 37.23
2016-06-30 254.28 11.30 36.51
2016-03-31 238.14 9.73 34.70
2015-12-31 226.59 10.27 33.66
2015-09-30 211.21 10.79 31.20
2015-06-30 192.95 11.81 28.98
2015-03-31 180.56 11.59 27.33
2014-12-31 168.48 10.02 25.48
2014-09-30 159.98 7.98 24.02
2014-06-30 153.78 6.97 22.52
2014-03-31 151.30 6.41 21.46
2013-12-31 147.81 6.87 20.68
2013-09-30 142.73 7.87 20.01
2013-06-30 138.42 6.95 19.92
2013-03-31 132.42 7.49 19.13
2012-12-31 132.17 7.76 18.68

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Mercator Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Mercator Medical used its assets less efficiently than the Europe Medical Equipment industry average last year based on Return on Assets.
  • It is difficult to establish if Mercator Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Mercator Medical's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Mercator Medical has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Mercator Medical's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Mercator Medical's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Mercator Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Mercator Medical's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Mercator Medical's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Mercator Medical Company Filings, last reported 3 months ago.

WSE:MRC Past Debt and Equity Data
Date (Data in PLN Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 133.96 133.43 19.19
2018-12-31 133.29 150.07 16.21
2018-09-30 131.59 143.80 11.25
2018-06-30 129.85 136.64 11.86
2018-03-31 126.76 127.41 33.74
2017-12-31 119.74 88.64 20.79
2017-09-30 120.05 73.62 10.33
2017-06-30 117.74 62.29 13.48
2017-03-31 122.27 53.31 22.47
2016-12-31 123.46 39.93 22.10
2016-09-30 116.78 46.61 8.76
2016-06-30 82.31 54.04 7.59
2016-03-31 74.66 50.63 6.84
2015-12-31 72.70 45.42 8.79
2015-09-30 68.47 50.19 5.74
2015-06-30 68.31 27.14 5.75
2015-03-31 71.92 47.31 5.34
2014-12-31 64.45 36.02 6.85
2014-09-30 65.66 29.07 6.99
2014-06-30 60.47 21.64 6.10
2014-03-31 58.11 21.78 10.86
2013-12-31 57.13 26.49 13.05
2013-09-30
2013-06-30 30.12 40.16 2.75
2013-03-31 24.69 36.45 3.44
2012-12-31 24.69 36.03 3.44
  • Mercator Medical's level of debt (100.6%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (38.5% vs 100.6% today).
  • Debt is not well covered by operating cash flow (17.9%, less than 20% of total debt).
  • Mercator Medical is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Mercator Medical's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Mercator Medical has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Mercator Medical's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Mercator Medical dividends.
If you bought PLN2,000 of Mercator Medical shares you are expected to receive PLN0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Mercator Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Mercator Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
WSE:MRC Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 40 Stocks 1.5%
Poland Market Average Dividend Yield Market Cap Weighted Average of 203 Stocks 4.3%
Poland Minimum Threshold Dividend Yield 10th Percentile 1.4%
Poland Bottom 25% Dividend Yield 25th Percentile 2.9%
Poland Top 25% Dividend Yield 75th Percentile 7.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

WSE:MRC Future Dividends Estimate Data
Date (Data in PLN) Dividend per Share (annual) Avg. No. Analysts
WSE:MRC Past Annualized Dividends Data
Date (Data in PLN) Dividend per share (annual) Avg. Yield (%)
2018-11-15 0.000 0.000
2018-08-29 0.000 0.000
2018-05-15 0.000 0.000
2018-03-19 0.000 0.000
2017-03-17 0.130 0.734
2015-05-13 0.250 1.517
2015-03-16 0.250 1.451
2015-01-15 0.250 1.777
2014-11-10 0.030 0.246
2014-08-26 0.030 0.277
2014-05-15 0.030 0.258
2014-03-20 0.030 0.228

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Mercator Medical has not reported any payouts.
  • Unable to verify if Mercator Medical's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Mercator Medical's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Mercator Medical has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Mercator Medical's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.4%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Mercator Medical afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Mercator Medical has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Mercator Medical's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Wieslaw Zyznowski
COMPENSATION PLN480,000
AGE 55
TENURE AS CEO 9.5 years
CEO Bio

Dr. Wieslaw Zyznowski has been the Chairman of Management Board at Mercator Medical Spólka Akcyjna since 2010. In the 90s Dr. Zyznowski co-founded the Mercator. From 1991 to 2001 he served as (apart from an interruption) a partner and Chairman of the Board of Mercator Zyznowski Trading Company S.J., converted in 1993 to Mercator Med. S.A. and Mercator Printing S.A., and later chairman of the supervisory boards of the companies Mercator Printing S.A. from 2001 to 2007 and Mercator Medical S.A. (1996?2010). He is also the owner of Baza Wieslaw Zyznowski in Siercza near Wieliczka, a property management firm and of the micropublisher Zyznowski (www.zyznowski.pl). He specialises in the philosophy of entrepreneurship, as well as being the publisher and author of books about the Wieliczka region and a manager and entrepreneur. He graduated from the University of Economics in Cracow (now Economic University) and the Faculty of Philosophy at Jagiellonian University, where he is now a PhD student in philosophy, preparing a work entitled ‘Man of profit in the philosophy and culture of ancient Greece’.

CEO Compensation
  • Wieslaw's compensation has increased whilst company is loss making.
  • Wieslaw's remuneration is higher than average for companies of similar size in Poland.
Management Team Tenure

Average tenure and age of the Mercator Medical management team in years:

5
Average Tenure
55
Average Age
  • The tenure for the Mercator Medical management team is about average.
Management Team

Wieslaw Zyznowski

TITLE
Chairman of Management Board
COMPENSATION
PLN480K
AGE
55
TENURE
9.5 yrs

Leszek Michnowski

TITLE
Vice President of the Management Board
COMPENSATION
PLN397K
AGE
58
TENURE
6.3 yrs

Witold Kruszewski

TITLE
CFO & Member of Management Board
COMPENSATION
PLN360K
TENURE
3.7 yrs

Monika Durakiewicz

TITLE
Member of the Management Board
COMPENSATION
PLN47K
AGE
33
TENURE
1.8 yrs
Board of Directors Tenure

Average tenure and age of the Mercator Medical board of directors in years:

5.9
Average Tenure
50
Average Age
  • The tenure for the Mercator Medical board of directors is about average.
Board of Directors

Urszula Zyznowska

TITLE
Chairwoman of Supervisory Board
AGE
48
TENURE
9.5 yrs

Piotr Solorz

TITLE
Vice Chairman of Supervisory Board
AGE
48

Marian Slowiaczek

TITLE
Member of Supervisory Board
AGE
69
TENURE
5.9 yrs

Jaroslaw Karasinski

TITLE
Member of Supervisory Board
AGE
52
TENURE
5.1 yrs

Gabriela Stolarczyk-Zadecka

TITLE
Member of the Supervisory Board
AGE
50
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (PLN) Value (PLN)
X
Management checks
We assess Mercator Medical's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Mercator Medical has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Could The Mercator Medical S.A. (WSE:MRC) Ownership Structure Tell Us Something Useful?

See our latest analysis for Mercator Medical WSE:MRC Ownership Summary, July 10th 2019 What Does The Institutional Ownership Tell Us About Mercator Medical? … Insider Ownership Of Mercator Medical The definition of company insiders can be subjective, and does vary between jurisdictions. … I can report that insiders do own shares in Mercator Medical S.A..

Simply Wall St -

What You Should Know About Mercator Medical S.A.'s (WSE:MRC) Financial Strength

With this increase in debt, MRC's cash and short-term investments stands at zł16m to keep the business going. … Looking at MRC’s zł162m in current liabilities, it seems that the business has been able to meet these commitments with a current assets level of zł193m, leading to a 1.19x current account ratio. … Next Steps: Although MRC’s debt level is towards the higher end of the spectrum, its cash flow coverage seems adequate to meet obligations which means its debt is being efficiently utilised.

Simply Wall St -

Some Mercator Medical (WSE:MRC) Shareholders Have Copped A Big 57% Share Price Drop

To wit the share price is down 57% in that time. … Even if you look out three years, the returns are still disappointing, with the share price down (the share price is down 55%) in that time. … Even though the Mercator Medical share price is down over the year, its EPS actually improved.

Simply Wall St -

Read This Before Judging Mercator Medical S.A.'s (WSE:MRC) ROE

This article is for those who would like to learn about Return On Equity (ROE). … Our data shows Mercator Medical has a return on equity of 5.3% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Does Mercator Medical S.A. (WSE:MRC) Have A Good P/E Ratio?

The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). … Mercator Medical has a price to earnings ratio of 14.65, based on the last twelve months. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

Mercator Medical S.A. (WSE:MRC): Time For A Financial Health Check

While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Companies operating in the Medical Equipment industry,. … Assessing first and foremost the financial health is

Simply Wall St -

What Type Of Shareholder Owns Mercator Medical S.A.'s (WSE:MRC)?

A look at the shareholders of Mercator Medical S.A. … Mercator Medical is a smaller company with a market capitalization of zł142m, so it may still be flying under the radar of many institutional investors. … institutional investors have bought into the company.

Simply Wall St -

Is Mercator Medical S.A.'s (WSE:MRC) 6.9% ROE Worse Than Average?

Mercator Medical has a ROE of 6.9%, based on the last twelve months. … One way to conceptualize this, is that for each PLN1 of shareholders' equity it has, the company made PLN0.069 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Do You Know What Mercator Medical S.A.'s (WSE:MRC) P/E Ratio Means?

We'll look at Mercator Medical S.A.'s (WSE:MRC) P/E ratio and reflect on what it tells us about the company's share price. … Based on the last twelve months, Mercator Medical's P/E ratio is 13.15. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Simply Wall St -

Is Mercator Medical SA's (WSE:MRC) CEO Overpaid Relative To Its Peers?

First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Wieslaw Zyznowski's Compensation Compare With Similar Sized Companies. … According to our data, Mercator Medical SA has a market capitalization of zł125m, and pays its CEO total annual compensation worth zł480k.

Simply Wall St -

Company Info

Description

Mercator Medical S.A., together with its subsidiaries, produces medical gloves and distributes medical disposables primarily in Poland, other European countries, and Russia. The company offers surgical gloves for conducting invasive surgeries that require sterile conditions; sterile examination and protective gloves for medical, outpatient, and diagnostic examinations, as well as therapeutic activities and working with septic materials; household gloves for use in gardening, household and sanitary work, and beauty treatments; and protective and heavy-duty gloves. It also provides dressing products, such as gauze, non-woven fabric, surgical dressings, and plaster of Paris dressing products, as well as medical adhesive tapes, and elastic tubular bandages and gauze rolls; and medical protective clothing, including caps, masks, medical coats and gowns, shoe covers, oversleeves, and coveralls. In addition, the company offers surgical drapes comprising sheets; non-woven drapes; surgical packs; and additional sterile items, which supplement the drape packs for the surgical site. Further, it provides professional services to food processing industry and gastronomy, pharmacies, and cosmetology, as well as to uniformed services. The company markets its products under the ambulance, comfort, dermaGEL, gynoglove, ideal, microtex, nitrylex, opero, orthopeg, proHAND, safeLINE, santex, syntec, texident, and vinylex brands. It primarily serves hospitals, clinics, outpatient departments, doctor’s offices, and dental and veterinary clinics through direct sales, as well as through partners, tenders, and wholesale and retail sales. Mercator Medical S.A. was founded in 1989 and is headquartered in Kraków, Poland.

Details
Name: Mercator Medical S.A.
MRC
Exchange: WSE
Founded: 1989
PLN72,535,335
10,589,100
Website: http://mercatormedical.eu
Address: Mercator Medical S.A.
Ul. H. Modrzejewskiej 30,
Kraków,
31-327,
Poland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
WSE MRC Bearer Shares Warsaw Stock Exchange PL PLN 17. Jan 2014
Number of employees
Current staff
Staff numbers
0
Mercator Medical employees.
Industry
Health Care Supplies
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/17 21:47
End of day share price update: 2019/07/17 00:00
Last estimates confirmation: 2019/03/25
Last earnings filing: 2019/05/17
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.